Education
About Us
Working with TipRanks
Follow Us
VETOQUINOL (FR:VETO)
:VETO
VETO Stock Chart & Stats
Day’s Range― - ―
52-Week Range€63.60 - €102.80
Previous CloseN/A
Volume18.00
Average Volume (3M)2.65K
Market Cap
€903.52M
Enterprise Value€671.43M
Total Cash (Recent Filing)€206.33M
Total Debt (Recent Filing)€21.12M
Price to Earnings (P/E)15.4
Beta0.47
Next Earnings
Sep 11, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 04, 2025Dividend Yield1.01%
Share Statistics
EPS (TTM)2.96
Shares Outstanding11,881,902
10 Day Avg. Volume2,753
30 Day Avg. Volume2,645
Financial Highlights & Ratios
PEG Ratio0.59
Price to Book (P/B)1.49
Price to Sales (P/S)0.00
P/FCF Ratio11.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€120.00Price Target Upside57.07% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
VETOQUINOL News
Bulls Say, Bears Say
Bulls Say
Earnings GrowthVetoquinol's adjusted EBIT has returned to growth for the first time in 3 years, marking the start of a positive upturn.
Financial PerformanceThe company's high gross margin and strong financial resources are expected to accelerate EPS growth.
Bears Say
Potential DelistingThe group has a net cash position of at least €150m, representing firepower of €450m, which may incentivize the majority shareholder to attempt to delist the company if the strong discount persists.
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
4.14%
Mutual Funds
― Other Institutional Investors
95.81% Public Companies and
Individual Investors
VETO FAQ
What was VETOQUINOL’s price range in the past 12 months?
VETOQUINOL lowest stock price was €63.60 and its highest was €102.80 in the past 12 months.
What is VETOQUINOL’s market cap?
VETOQUINOL’s market cap is €903.52M.
When is VETOQUINOL’s upcoming earnings report date?
VETOQUINOL’s upcoming earnings report date is Sep 11, 2025 which is in 66 days.
How were VETOQUINOL’s earnings last quarter?
VETOQUINOL released its earnings results on Mar 20, 2025. The company reported €2.956 earnings per share for the quarter, beating the consensus estimate of N/A by €2.956.
Is VETOQUINOL overvalued?
According to Wall Street analysts VETOQUINOL’s price is currently Undervalued.
Does VETOQUINOL pay dividends?
VETOQUINOL pays a Annually dividend of €0.772 which represents an annual dividend yield of 1.01%. See more information on VETOQUINOL dividends here
What is VETOQUINOL’s EPS estimate?
VETOQUINOL’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VETOQUINOL have?
VETOQUINOL has 11,881,902 shares outstanding.
What happened to VETOQUINOL’s price movement after its last earnings report?
VETOQUINOL reported an EPS of €2.956 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.224%.
Which hedge fund is a major shareholder of VETOQUINOL?
Currently, no hedge funds are holding shares in FR:VETO
Company Description
VETOQUINOL
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, and dogs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.